Keywords: Sanofi, Multaq, USA, FDA, Atrial fibrilation

US FDA now joins in probe of Sanofi’s Multaq safety

Article | 25 July 2011

Print This

The US Food and Drug Administration says it is reviewing data from a clinical trial that was evaluating the effects ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in